14 ASEICA INTERNATIONAL CONGRESS14th-international-congress-aseica.aseica.es/wp-content/... ·...

14th

ASEICAINTERNATIONALCONGRESSSpanish Society for Cancer Research

Madrid · 23rd-25th September 2013Hospital universitario Ramón y Cajal

SaludMadrid

Hospital UniversitarioRamón y Cajal

Comunidad de Madrid

Organizing COmmittee

PresidentDr. Montse Sánchez-Céspedes

Dr. Alfredo CarratoDr. Félix BonillaDr. Trinidad CaldésDr. Gabriel CapellàDr. Pedro Lazo-ZbikowskiDr. Ana OsorioDr. Luis Paz-AresDr. José Antonio Rodríguez

SCientifiC COmmittee

Dr. Montse Sánchez-CéspedesDr. Alfredo CarratoDr. Andrés AguileraDr. Javier BenítezDr. Félix BonillaDr. Trinidad CaldésDr. Amparo CanoDr. Gabriel CapellàDr. Luis Del Peso

Dr. Manel EstellerDr. Manuel HidalgoDr. Pedro Lazo-ZbikowskiDr. Ana OsorioDr. Luis Paz-AresDr. Miguel Ángel PirisDr. José Antonio RodríguezDr. Isidro SánchezDr. Manuel Serrano

mOnDaY 23rd SePtemBer 2013

Schedule Salón de actos aula Docencia

08:00_10:00h Registration

09:00_11:00h SYMPOSIUM I: Novel cancer targets andtherapeutic approaches discovery

11:00_11:30h Coffee break and poster viewing

11:30_12:30h LECTURE I: Drugging the cancer genome:recent discoveries with kinases and Hsp90

12:30_13:00h Opening ceremony

13:00_14:30h Lunch and poster viewing

14:30_17:15h VI RTICC ANNUAL MEETING


17:45_20:15h VI RTICC ANNUAL MEETING

tueSDaY 24th SePtemBer 2013


08:30_10:30h SYMPOSIUM II: Wide genome analysis of human cancers


11:00_13:00h SYMPOSIUM III: Epigenetics andmicroenvironment

SYMPOSIUM IV: Deregulation of cellmetabolism in cancer development


14:00_15:00h LECTURE II: Cancer research in the genomic era: from genes to genomes

15:00_17:00 SYMPOSIUM V: Cancer progression and metastasis SYMPOSIUM VI: Stem cells and cancer

17:00_17:30 Coffee break and poster viewing

17:30_19:30 SYMPOSIUM VII: DNA damage andcancer development

WeDneSDaY 25th SePtemBer 2013


09:00_11:00h SYMPOSIUM VIII: Noncoding RNAs and cancer SYMPOSIUM Ix: Hypoxia and angiogenesis


11:30_13:00h PRESIDENTIAL SYMPOSIUM


14:00_14:30h ASEICA Assembly

08:00_10:00regiStratiOn

09:00_11:00SYmPOSium i

nOvel CanCer targetS anD theraPeutiC aPPrOaCheS DiSCOverYChairpersons Dr. Alfredo Carrato and Dr. Manuel Hidalgo

new targets and therapeutic strategies in pancreatic cancerDr. Manuel Hidalgo, Hospital de Madrid Norte Sanchinarro-CIOCCy Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid

introducing rna therapeutics in the clinicDr. Josep Mª Tabernero, Hospital General Universitari Vall d’Hebron, Barcelona

Selected oral communications *see annex

11:00_11:30COffee Break anD POSter vieWing

11:30_12:30leCture iChairperson Dr. Josep Mª Tabernero

Drugging the cancer genome: recent discoveries with kinases and hsp90Dr. Paul Workman, The Institute of Cancer Research, London, UK

12:30_13:00OPening CeremOnY

13:00_14:30lunCh anD POSter vieWing

14th ASEICAINTERNATIONAL CONGRESS

MONDAY 23rd SEPTEMBER 2013

vi rtiCCANNUAL MEETING 201314:30_15:00OPening CeremOnYDr. Antonio L. Andreu, Director General del Instituto de Salud Carlos III (ISCIII), MadridDr. Eugenio Santos, Coordinador Nacional de la RTICC y Centro de Investigacióndel Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CIC-IBMCC), SalamancaDr. Javier Maldonado, Gerente del Hospital Universitario Ramón y Cajal, MadridDr. Alfredo Carrato, Hospital Universitario Ramón y Cajal, Madrid

15:00_16:00OPening COnferenCe:SignatureS Of mutatiOnal PrOCeSSeS in human CanCerDr. Ludmil Alexandrov, Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK

16:00_16:30rtiCC natiOnal COOrDinatOr COnferenCe:rtiCC 2013 uPDateDr. Eugenio Santos, Coordinador Nacional de la RTICC, Centro de Investigacióndel Cáncer-Instituto de Biología Molecular y Celular del Cáncer (CIC-IBMCC), Salamanca

16:30_16:45aWarDS: rtiCC Prize fOr COOPerative reSearCh in OnCOlOgY 2013

16:45_17:15 aWarDeD PrOjeCt PreSentatiOn: rtiCC Prize fOr COOPerative reSearCh in OnCOlOgY 2013

17:15_17:45 COffee Break anD POSter vieWing


17:45_18:05ePiDemiOlOgY anD CanCer PreventiOn PrOgram: PriOritieS fOr reSearCh in CanCer ePiDemiOlOgY anD PreventiOn: the rtiCC PerSPeCtiveDr. Josep Maria Borràs, Institut Català d’Oncologia (ICO)-IDIBELL, Barcelona

18:05_18:25hematOlOgiCal tumOrS PrOgram:When tO tranSPlant aCute mYelOiD leukemia PatientS BaSeD On gene-tiC featureS Of the DiSeaSe: regiStrieS anD netWOrkS exPerienCeSDr. Jordi Sierra, Hospital de la Santa Creu i Sant Pau, Barcelona

18:25_18:45BreaSt CanCer PrOgram:BreaSt CanCer tranSlatiOnal reSearChDr. Joaquín Arribas, Institut d’Oncologia Vall d’Hebron (VHIO), Barcelona

18:45_19:05COlOreCtal anD DigeStive traCt tumOrS PrOgram:COlOreCtal CanCer tranSlatiOnal reSearChDr. Gabriel Capellà, Institut Català d’Oncología (ICO)-IDIBELL, Barcelona

19:05_19:25lung anD reSPiratOrY traCt tumOrS PrOgram:rtiCC lung anD uPPer reSPiratOrY traCt CanCer PrOgram: SummarY Of OBjeCtiveS anD uPDate Of aChievementSDr. Luis Montuenga, Centro para la Investigación Médica Aplicada (CIMA), Pamplona



19:25_19:45Other SOliD anD PeDiatriC tumOrS PrOgram:POtential anD aCtual SYnergieS in the fielD Of PeDiatriC, gYneCOlOgiCal anD neural SYStem CanCer reSearChDr. Enrique de Álava, Centro de Investigación del Cáncer-Instituto de Biología Moleculary Celular del Cáncer (CIC-IBMCC), Salamanca

19:45_20:05mOleCular meChaniSmS: mOleCular tumOr CharaCterizatiOn, CanCer genOmiCS anD BiOmarkerS PrOgram:mOleCular meChaniSmS PrOgram: uPDate aCtivitieS 2013Dr. Eugenio Santos and Dr. xosé R. Bustelo, Centro de Investigación del Cáncer-Instituto de Biolo-gía Molecular y Celular del Cáncer (CIC-IBMCC), Salamanca

20:05_20:15ClOSing CeremOnY rtiCC annual meeting


vi rtiCCANNUAL MEETING 2013

08:30_10:30SYmPOSium ii: WiDe genOme analYSiS Of human CanCerSChairpersons Dr. Montse Sánchez-Céspedes and Dr. Javier Benítez

genomic landscapes of the 10 breast cancer subtypesDr. Carlos Caldas, Cambridge Cancer Center, Cambridge, UK

exome sequencing: from research to clinical applicationDr. Javier Benítez, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid



11:00_13:00SYmPOSium iii: ePigenetiCS anD miCrOenvirOnmentChairpersons Dr. Luis Paz-Ares and Dr. Manel Esteller

myc inhibition as a therapeutic strategy in cancerDr. Laura Soucek, Fundació VHIO, Barcelona

human cancer epigenetics: from knowledge to applicationDr. Manel Esteller, IDIBELL- Hospital Duran y Reynals, Barcelona


SYmPOSium iv: DeregulatiOn Of Cell metaBOliSm in CanCer DevelOPmentChairpersons Dr. Ana Osorio and Dr. Manuel Serrano

exploiting cellular metabolism for cancer detection and treatmentDr. Arkaitz Carracedo, CIC bioGUNE, Bizkaia

Sirt1 and Pi3k in cancer and metabolismDr. Manuel Serrano, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid



TUESDAY 24th SEPTEMBER 2013


14:00_15:00leCture iiChairperson Dr. Carlos Caldas

Cancer research in the genomic era: from genes to genomesDr. Carlos López Otín, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Oviedo

15:00_17:00SYmPOSium v: CanCer PrOgreSSiOn anD metaStaSiSChairpersons Dr. Félix Bonilla and Dr. Amparo Cano

emt reversibility in development and cancerDr. Ángela Nieto, CISC- Universidad Miguel Hernández, Alicante

regulation of cell plasticity and metastasis by lysyl oxidase-like 2Dr. Amparo Cano, Instituto Investigaciones Biomédicas (CSIC-UAM), Madrid


SYmPOSium vi: Stem CellS anD CanCerChairpersons Dr. José Antonio Rodríguez and Dr. Isidro Sánchez

role of polycomb in gene transcription, development and cancerDr. Luciano Di Croce, Institut Català de Recerca i Estudis Avançats (ICREA), Barcelona

Stem cell reprogramming as a driver of cancer: implications in its development and treatmentDr. Isidro Sánchez, Instituto de Biología Molecular y Celular del Cáncer (IBMC), Salamanca




17:30_19:30SYmPOSium vii: Dna Damage anD CanCer DevelOPmentChairpersons Dr. Pedro Lazo-Zbikowski and Dr. Andrés Aguilera

targeting oncogene-induced Dna damage for cancer therapyDr. Óskar Fernández-Capetillo, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid

a new role for tumor suppressors in the removal of r-loops responsible for genome instabilityDr. Andrés Aguilera, Universidad de Sevilla- CABIMER, Sevilla




09:00_11:00SYmPOSium viii: nOnCODing rnaS anD CanCerChairpersons Dr. Trinidad Caldés and Dr. Miguel Ángel Piris

micrornas in lymphoid malignancies. new tools for a better understanding, diagnosis and treatmentDr. Miguel Ángel Piris, IFIMAV, Hospital Marqués de Valdecilla, Santander

micrornas as oncogenes and tumor suppressors in cancer developmentDr. Pedro Medina, Center for Genomics and Oncology Research, University of Granada, Granada


SYmPOSium ix: hYPOxia anD angiOgeneSiSChairpersons Dr. Gabriel Capellà and Dr. Luis del Peso

the oxygen sensing hif pathways and cancer cell proliferationDr. Julián Aragonés, Hospital Universitario de La Princesa, Madrid

hif and PhDs-mediated hypoxia toleranceDr. Edurne Berra, CIC bioGUNE, Bizkaia

regulation of angiogenesis by notch and its relevance in cancerDr. Rui Benedito, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid

regulation of gene expression by hypoxiaDr. Luis del Peso, Instituto Investigaciones Biomédicas (CSIC-UAM), Madrid



WEDNESDAY 25th SEPTEMBER 2013

11:30_13:00PreSiDential SYmPOSium Chairpersons Dr. Alfredo Carrato and Dr. Montse Sánchez-Céspedes

aSeiCa awards: Best recent publications by young scientists *see annex


14:00_14:30aSeiCa aSSemBlY


WEDNESDAY 25th SEPTEMBER 2013

SYmPOSium i: nOvel CanCer targetS anD theraPeutiC aPPrOaCheS DiSCOverY

Serum sCD26 fOr COlOreCtal CanCer SCreening in familY-riSk POPulatiOnOlalla Otero Estévez, Dpto. de Bioquímica, Genética e Inmunología, Universidad de Vigo, Vigo

SPrY1 iS a neW target Of the eWS/fli1 OnCOPrOtein in eWing SarCOma CellSFlorencia Cidre Aranaz, Instutito de Salud Carlos III - Instituto de Investigación en Enfermedades Raras, Madrid

DaratumumaB, a nOvel human CD38 mOnOClOnal antiBODY fOr the treatment Of B-Cell nOn–hODgkin lYmPhOmaAnna Vidal Crespo, Department of Hemato-Oncology, IDIBAPS, Barcelona

kineSin familY memBer 3B aS a nOvel meDiatOr in PanCreaS CanCerMiren Edurne Ramos, Pathology Dpt., Hospital Universitario Ramón y Cajal, IRYCIS, Madrid

SYmPOSium ii: WiDe genOme analYSiS Of human CanCerS

myomirs (mir-1/133a mir-206/133b) anD met OnCOgene, ShOWS CO-DeregulatiOn in veStiBular SChWannOmaMiguel Torres Martín, Neuro-Oncogenetics Laboratory, Research Unit, Hospital UniversitarioLa Paz, IdiPAZ, Madrid

tranSgeniC miCe Bearing aCtive mutageniC tranSPOSOnS fOr the DeterminatiOn Of BreaSt CanCer geneSÁngel Ramírez, Molecular Oncology Unit, Centro de Investigaciones Energéticas, Tecnológicas y Medioambientales (CIEMAT), Madrid

CiS-regulatOrY gene exPreSSiOn SnPs anD methYlatiOn Quantitative trait lOCi in COlOreCtal CanCerLaia Paré Brunet, Unit of Biomarkers and Susceptibility, Cancer Prevention and Control Program, IDIBELL – Institut Català d’Oncologia (ICO) and CIBERESP, Barcelona

genetiC anD PhenOtYPiC CharaCterizatiOn Of familieS With familial PanCreariC CanCer anD SCreening Of high-riSk inDiviDualSCarmen Guillén Ponce, Familial Cancer Unit, Medical Oncolgy Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid

ANNEx · SELECTED ORAL COMMUNICATIONS

SYmPOSium iii: ePigenetiCS anD miCrOenvirOnment

the ChrOmatin remODeler ChD8 iS reQuireD fOr tranSCriPtiOn aCtivatiOn Of S-PhaSe geneSAlicia Subtil Rodríguez, Molecular Biology Department, Centro Andaluz de Biología Molecular y Medicina Regenerativa (CABIMER), Consejo Superior de Investigaciones Científicas (CSIC), Sevilla

Differential effeCtS Of rOmiDePSin, a hiStOne DeaCetYlaSe inhiBitOr, in B-Cell lYmPhOmaS anD BCl6 gene regulatiOnMaría G. Cortiguera, Dpto. Biología Molecular-IBBTEC, Universidad de Cantabria, Santander

meChaniSm Of De nOvO reSiStanCe tO 5fu anD OxaliPlatin inDuCeD BY CarCinOma-aSSOCiateD fiBrOBlaStS in COlOreCtal CanCerSamuel Gonçalves Ribeiro, IDIBELL, Barcelona

meChaniSmS Of SmarCa4 inaCtivatiOn in lung CarCinOgÉneSiSPaola Peinado Fernández, Universidad de Granada y Centro GenyO de Investigación Oncológica, Granada

SYmPOSium iv: DeregulatiOn Of Cell metaBOliSm in CanCer DevelOPment

funCiOnal anD genOmiC analYSiS iDentifY the laCtate tranSPOrter mCt4 aS a POtential metaBOliC target in renal Cell CarCinOmaClaudio Santos, Translational Cancer Therapeutics Laboratory, Cancer Research UK,London Research Institute, London, UK

alteratiOnS in aminOaCiD metaBOliSm in PrOState CanCerAmaia Arruabarrena Aristorena, CIC bioGUNE, Bizkaia

SOmatiC vhl gene alteratiOn in hereDitarY anD SPOraDiC heaD anD neCk ParagangliOmaS: iDentifiCatiOn Of a nOvel targetAna Merlo, Hospital Universitario Central de Asturias and Instituto Universitario de Oncología del Principado de Asturias, Oviedo

SYmPOSium v: CanCer PrOgreSSiOn anD metaStaSiS

rOle Of SOn Of SevenleSS PrOteins, SOS1 anD SOS2, in miCe Skin tumOr initia-tiOn anD DevelOPmentPilar Liceras-Boillos, Instituto de Biología Molecular y Celular del Cáncer (USAL-CSIC), Salamanca



DiOxin reCePtOr DifferentiallY aCtS On the tumOr Cell anD the miCrOenvirOnment tO SuPPreSS melanOma grOWth anD metaStaSiSMaría Contador, Dpto. de Bioquímica y Biología Molecular, Universidad de Extremadura, Cáceres

the nuClear COrePreSSOr nCor iS an eSSential meDiatOr Of the anti-tumOrigeniC anD anti-metaStatiC aCtiOnS Of the thYrOiD hOrmOne reCePtOr βOlaia Martínez-Iglesias, Instituto de Investigaciones Biomédicas, Consejo Superior de Investiga-ciones Científicas and Universidad Autónoma de Madrid, Madrid

regulatiOn Of PrOtein tranSlatiOn anD c-jun exPreSSiOn BY PrOState tumOr OverexPreSeD 1 (PtOv1)Verónica Cánovas, Research Unit in Biomedicine, Translational and Pediatrics Oncology, Institut de Recerca Vall d’Hebron and Universitat Autònoma, Barcelona

SYmPOSium vi: Stem CellS anD CanCer

rOle Of the miDkine / anaPlaSiC lYmPhOma kinaSe axiS in gliOma Stem CellSDavid Dávila, Department of Biochemistry and Molecular Biology I, School of Biology, Universidad Complutense, Madrid

OSteOSarCOma generatiOn frOm C-fOS exPreSSing human meSenChYmal Stem Ander Abarrategui, Instiuto de Salud Carlos III, Madrid

exPreSSiOn Of fuS-ChOP fuSiOn PrOtein in immOrtalizeD/tranSfOrmeD human meSenChYmal Stem CellS DriveS mixOiD liPOSarCOma fOrmatiOnRené Rodríguez, Hospital Universitario Central de Asturias and Instituto Universitario de Oncolo-gía del Principado de Asturias, Oviedo

a nOvel mOleCular meChaniSm invOlveD in CanCer DevelOPment revealeD BY targeting mafB tO hematOPOietiC PrOgenitOrSCarolina Vicente Dueñas, Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer (CSIC), Universidad de Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Salamanca


SYmPOSium vii: Dna Damage anD CanCer DevelOPment

exPlOring the rOle Of eWSr1 in rePliCatiOn StreSSIsabel Morgado Palacín, Genomic Instability Group, Centro Nacional de InvestigacionesOncológicas (CNIO), Madrid

regulatiOn Of the COmPlexeS invOlveD in Dna-Damage reSPOnSe BY vrk1Marcella Salzano, Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas-Universidad de Salamanca, Campus Miguel de Unamuno, Salamanca

a lOCalizeD DDr iS aCtivateD at the miDBODY tO reSOlve Dna BriDgeSMaría Nieto Soler, Genomic Instability Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid

Cell CYCle-DePenDent PhOSPhOrYlatiOn anD DegraDatiOn Of kSr1José Lozano, Universidad de Málaga, Málaga

a COnDitiOnal knOCk-in mOuSe mODel revealS eSSential rOleS Of BrCa1 uBiQuitin ligaSe aCtivitYAndrés López Contreras, Genomic Instability Group, Centro Nacional de InvestigacionesOncológicas (CNIO), Madrid

alteratiOnS Of a mitOSiS -DifferentiatiOn CheCkPOint anD genOmiC inStaBilitY in Skin CarCinOma CellSPilar Alonso Lescure, Cell Cycle, Stem Cell fate and Cancer Lab, FMDV-IFIMAV, Santander

rOle Of human POlD3 in genOme integritYEmanuela Tumini, Centro Andaluz de Biología Molecular y Medicina Regenerativa – CABIMER, Universidad de Sevilla, Sevilla

SYmPOSium viii: nOnCODing rnaS anD CanCer

CYtOSine-5 methYlatiOn in trna PrOteCtS Skin frOm uv anD OxiDative StreSS DamageSandra Blanco, Wellcome Trust – Medical Research Council Stem Cell Institute, University ofCambridge, Cambridge, UK

multiPlexeD ngS fOr mirna PrOfiling in reSeCtaBle nOn Small Cell lung CanCerSandra Gallach, Laboratorio Oncología Molecular, Fundación para la Investigación del Hospital General Universitario de Valencia, Valencia



genOme-WiDe mirna exPreSSiOn analYSiS Of thYrOiD CanCer BY ngS iDentifieS mir-146b-3p aS a keY regulatOr Of thYrOiD DifferentiatiOnGarcilaso Riesco Eizaguirre, Instituto de Investigaciones Biomédicas CSIC-UAM / IdiPAZ / Hospital Universitario de Móstoles, Madrid

PeriPheral BlOOD miCrOrnaS exPreSSiOn PrOfile: a fingerPrint fOr metaStatiC PrOState CanCerV. Medina Villaamil, INIBIC, Oncology Area, Centro Hospitalario Universitario (CHUAC), A Coruña

SYmPOSium ix: hYPOxia anD angiOgeneSiS

SerrateD COlOreCtal aDenOCarCinOma ShOWS a Different PrOfile Of angiOgeniC markerS COmPareD tO COnventiOnal CarCinOmaMaría del Carmen Turpín Sevilla, Universidad Francisco de Vitoria, Madrid

COntraSting reSPOnSeS Of nOn-Small Cell lung CanCer tO antiangiOgeniC theraPieS DePenDing On hiStOlOgYJackeline Agorreta, Division of Oncology, Centro de Investigación Médica Aplicada, Universidad de Navarra, Pamplona

SOx9 funCtiOn in CanCerA. Matheu, Neurooncology group, Biodonostia Instituto de Investigación, San Sebastián

aSeiCa aWarDS: BeSt reCent PuBliCatiOnS BY YOung SCientiStSPreSiDential SYmPOSium:

awards:

an extra allele Of Chk1 limitS OnCOgene-inDuCeD rePliCative StreSS anD PrOmOteS tranSfOrmatiOnAndrés López Contreras, Genomic Instability Group, Centro Nacional de InvestigacionesOncológicas (CNIO), Madrid

DePenDenCY Of COlOreCtal CanCer On a tgf-Beta-Drive PrOgram in StrOmal CellS fOr metaStaSiS initiatiOnElisa María Espinet Hernández, Oncology Programme, Institut de Recerca Biomèdica (IRB), Barcelona




accesits:

germinal Centre PrOtein hgal PrOmOteS lYmPhOiD hYPerPlaSia anD amYlOiDOSiS via BCr-meDiateD SYk aCtivatiOnIsabel Romero Camarero, Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer (CSIC), Universidad de Salamanca, Institute of Biomedical Research of Salamanca (IBSAL), Salamanca

ePigenetiC DiSruPtiOn Of CaDherin-11 in human CanCer metaStaSiSFrancisco Javier Carmona Sanz, Cancer Epigenetics and Biology Program (PEBC), Bellvitge Bio-medical Research Institute (IDIBELL), Barcelona

amPk aCtivatiOn BY OnCOgeneSiS iS reQuireD tO maintain CanCer Cell PrOliferatiOn in aStrOCYtiC tumOrSMarcos Ríos García, Departamento de Fisioloxía, CIMUS, Facultad de Medicina, Santiago de Compostela

inhiBitiOn Of DYrk1a DeStaBilizeS egfr anD reDuCeS egfr-DePenDent gliOBlaStOma grOWthCristina Zahonero Casans, Neuro-oncology Unit, Instituto de Salud Carlos III- UFIEC, Madrid

Train RENFE

Bus L. 125 - 135

Metro

Lunch

ParkingP

HOSPITAL UNIVERSITARIORAMÓN Y CAJAL

LOCATION MAP

3

1 Salón de Actos

Aula Docencia - 1st floor(Pabellón Docente)

Coffee Break and posters

2

3

Hospital Universitario Ramón y Cajal

Ctra. de Colmenar Viejo km 9, 100 · MadridT. 91 336 80 00

Gold

Silver

Bronze

Under the auspices of

Technical Secretariat TACTICS MD

T. 93 451 17 24 [email protected]

14th

ASEICAINTERNATIONALCONGRESS

Accreditation requested to the Spanish System of Continuing Medical Education

The Home for Gene Technology

14 ASEICA INTERNATIONAL CONGRESS14th-international-congress-aseica.aseica.es/wp-content/... ·...

Documents

Transcript of 14 ASEICA INTERNATIONAL CONGRESS14th-international-congress-aseica.aseica.es/wp-content/... ·...